期刊文献+

前B细胞集落增强因子在炎症相关性疾病中的作用 被引量:3

Pre-B-cell colony-enhancing factors in inflammatory-related diseases
下载PDF
导出
摘要 人类前B细胞集落增强因子(pre-B-cell colony-enhancing factor,PBEF)首先被作为一种能够促进前B细胞集落形成的分子而被发现。近年来对PBEF的大量研究显示,PBEF在炎症与免疫、氧化应激、细胞凋亡和糖脂代谢等多种病理生理过程中发挥作用。PBEF在炎症中的作用可能通过其促炎细胞因子活性、Nampt酶活性和对免疫细胞凋亡的调控参与多种急性和慢性炎症过程。PBEF参与多种临床炎性疾病,如急性肺损伤、关节炎、感染所致的早产、炎性肠病、肾炎性疾病、脓毒症、肝炎、心血管慢性炎症等的病理过程,是炎症机制研究和治疗的新靶点。 Human pre-B cell colony-enhancing factor(PBEF) was first identified as a protein that stimulates early stage of B cell formation.Recently,it has been shown to be a multifunctional protein taking part in different pathological and physiological processes,including immunology/inflammation,oxidative stress,survival/longevity,and obesity/metabolism.The role of PBEF in inflammation may be exerted through its pro-inflammatory cytokine activity,Nampt enzymatic activity,and/or regulation of apoptosis in immune cells.Accumulating data associate PBEF with a variety of acute and chronic inflammatory conditions,including acute lung injury,arthritis,infection-induced preterm labor,inflammatory bowel disease,inflammatory kidney disease,sepsis,hepatitis and cardiovascular disease,etc.PBEF may be a new and potential target for studying inflammatory mechanisms and curing inflammatory diseases.
出处 《国际病理科学与临床杂志》 CAS 2012年第4期335-342,共8页 Journal of International Pathology and Clinical Medicine
基金 中南大学研究生教育教学改革与研究项目(2011jg23)~~
关键词 前B细胞集落增强因子 炎症 急性肺损伤 脓毒症 心血管疾病 pre-B-cell colony-enhancing factor; inflammation; acute lung injury; sepsis; cardiovascular disease
  • 相关文献

参考文献64

  • 1Ognjanovic S, Bao S, Yamamoto SY, et al. Genomic organization of the gene coding for human pre-B-cell colony enhancingfactor and expression in human fetalmembranes[J]. J Mol Endocrinol, 2001, 26 (2): 107-117.
  • 2Samal B, Sun Y, Stearns G, et al, Cloning and characterization ofthe cDNA encoding a novel human pre-B-cell colony-enhancing factor[J]. Mol Cell Biol, 1994, 14 (2): 1431-1437.
  • 3Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity[J]. J Leuk Biol, 2008, 83(4): 804-816.
  • 4Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells[J]. J Biol Chem, 2004, 279 (49) : 50754-50763.
  • 5Kitani T, Okuno S, Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony- enhancing factor [J]. FEBS Lett, 2003, 544 (123): 74-78.
  • 6Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apop tosis in experimental inflammation and clinical sepsis [J]. J Clin Invest, 2004, 113 (9): 1318-1327.
  • 7Macia'n F, Lo'pez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-I[J]. Oncogene, 2001, 20(19): 2476-2489.
  • 8Moschen AR, Geiger S, Gerner R, et al. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease[J]. Mutation Res, 2010, 690(1/2): 95-101.
  • 9Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin[J]. Science, 2005, 307(5708):426-430.
  • 10Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme[J]. Cell Metab, 2007,6(5): 363-375.

同被引文献41

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部